drug

MRT-8102

Phase 1updated 3mo ago

by $GLUE Monte Rosa Therapeutics, Inc.

Phase 1

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying MRT-8102

phase1A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRPrecruitingn=100

News(1)

Novo’s late-stage IL-6 stumble shakes inflammation space
Novo Nordisk was banking on the inflammatory benefits of its investigational therapy ziltivekimab to improve cardiovascular outcomes. Last week’s Phase 3 failure dashed not just the Danish pharma’s…
biospace · 12d ago

Data sources

ClinicalTrials.gov

last refreshed 30m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

MRT-8102

Phase 1updated 3mo ago

by $GLUE Monte Rosa Therapeutics, Inc.

Phase 1

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying MRT-8102

phase1A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRPrecruitingn=100

News(1)

Novo’s late-stage IL-6 stumble shakes inflammation space
Novo Nordisk was banking on the inflammatory benefits of its investigational therapy ziltivekimab to improve cardiovascular outcomes. Last week’s Phase 3 failure dashed not just the Danish pharma’s…
biospace · 12d ago

Data sources

ClinicalTrials.gov

last refreshed 30m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

MRT-8102

all catalysts(0)

Trials studying MRT-8102

News(1)

Report a data issue

comments(0)

MRT-8102

all catalysts(0)

Trials studying MRT-8102

News(1)

Report a data issue

comments(0)